Podcasts about untreated

Leaving a relationship with someone who has untreated borderline personality traits can feel less like a breakup and more like trying to escape a locked room while being told you're the one causing the fire.In this episode, I speak directly to the people who are rarely centered in these conversations: the partners who have been living inside someone else's emotional emergency. The ones who learned to scan tone, timing, silence, and mood shifts just to survive. The ones whose nervous systems became collateral damage.This is not an episode about diagnosing or vilifying people with BPD. It is about naming the relational impact of untreated emotional dysregulation, identity collapse, abandonment panic, and rage–care oscillation on the person who loves them.I talk about:Why leaving can feel impossible without intense guilt and fearHow reality erosion, false accusations, and emotional role reversal take holdThe cycle I see over and over again: rage → collapse → panic → pleading → accusationWhy reassurance makes things worse instead of betterHow partners slowly disappear while trying to keep someone else regulatedWhy intent does not cancel impact, even when suffering is realIf you've ever felt like you were the safest person in the world one moment and the villain the next—with no transition, no shared reality, and no way to win—this episode is for you.Support the show*Please Note: there is a long intro that explains my services. If you do not want to listen, just fast-forward 5 mins past. This intro will be changed in future recordings to be shorter. I am not paid to record this podcast and it is a free offering. Offering my work is the only way I can sustain the podcast* Join the Patreon: https://patreon.com/Youarenotcrazy *New Course*: Unhooked: Map the Cycle of Abuse in your Relationship Website: Emotional Abuse Coach and high-conflictdivorcecoaching.comInstagram: @emotionalabusecoachEmail: jessica@jessicaknightcoaching.com{Substack} Blog About Recovering from Abuse {E-Book} How to Break Up with a Narcissist{Course} Identify Signs of Abuse and Begin to Heal{Free Resource} Canned Responses for Engaging with an Abusive Partner

Danny Rensch was born into a cult that weaponized chess for prestige. He's here to explain how he broke free on part one of this two-part episode.Full show notes and resources can be found here: jordanharbinger.com/1289What We Discuss with Danny Rensch:Cults don't always start with sinister blueprints. The Church of Immortal Consciousness where Danny Rensch was raised grew from self-help roots and communal idealism into full financial control — where members surrendered everything, kids shared bathwater, and the shoe list became a euphemism for "you don't matter enough to get a pair."The cult weaponized chess the same way the Soviet Union did — as a tool for prestige. Danny was identified as a prodigy, deliberately separated from his mother, and groomed as the collective's golden child. His talent wasn't nurtured for his sake — it was exploited for the cult leader's ego.By age 13, Danny was living alone, traveling to national chess tournaments with pockets full of cash and no adult supervision. The neglect wasn't just emotional — it was physical. Untreated swimmer's ear became severe infection, leaving him 60% deaf in one ear and 40% in the other.A drunk, defecting Soviet grandmaster named Igor Ivanov — who once fled the KGB during an emergency plane stop — became Danny's live-in chess coach. Igor had carte blanche to drink and do as he pleased, making him the cult's most functional dysfunction and Danny's unlikely lifeline to the wider chess world.Despite growing up as a high school dropout in a cult with no formal education, Danny became a successful writer and helped build Chess.com — proof that curiosity, baseline intelligence, and sheer determination can outrun even the most rigged starting hand. Motivated people can learn faster than any institution expects them to.And much more...And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors: BetterHelp: 10% off first month: betterhelp.com/jordanGood Chop: $50 off + free shipping on first order: goodchop.com/podcast, code 50JORDANMomentous: 20% off first order: livemomentous.com, code JORDAN20Fundera by NerdWallet: Find the funding you deserve: nerdwallet.com/jordanTom Hardin | Tipper X: The Man Behind Wall Street's Biggest Sting | The Jordan Harbinger ShowWired on Wall Street: The Rise and Fall of Tipper X, One of the FBI's Most Prolific Informants by Tom HardinSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Let help uncork your memoir through a 12 week memoir mentorship program: https://mikecarlon.com/memoir-cohorts/ "Medicine knows a patient's disease, but it does not know the patient — and that is where the real crisis lies." — Dr. Robert Smith In this powerful episode of Uncorking a Story, Mike sits down with Dr. Robert Smith, a nationally recognized pioneer in evidence‑based mental health care and physician‑patient communication. Drawing from his new book Has Medicine Lost Its Mind?, Dr. Smith reveals how our current medical system inadequately prepares doctors for the most common health issues in America — mental health conditions — and why this failure is costing lives, families, and entire communities. From formative early-career mistakes to the creation of the first patient‑centered interviewing method, Dr. Smith shares a compelling journey of awakening, reform, and hope. If you've ever wondered why navigating mental health care feels so broken — or what it would take to fix it — this conversation is essential listening. Key Takeaways: The mental health crisis is rooted in medical education. Doctors receive only 2% of training in mental health, despite mental illness being the most common health condition in the U.S.  A powerful personal failure reshaped Dr. Smith's career. A patient's diary — detailing how unheard she felt — sparked his lifelong mission to reform how physicians communicate and treat mental health.  Primary care doctors handle most mental health cases — untrained. Psychiatrists see only about 12% of mental health patients; primary care sees the rest, often without adequate preparation.  The mind–body split dates back to the 1500s. Deep historical roots shape modern medicine's exclusion of psychological and social factors, to the detriment of today's patients.  Untreated mental illness drives society-wide consequences. Divorce, addictions, homelessness, incarceration, and even suicide can often be traced back to missed diagnoses in primary care.  Dr. Smith proposes a Second Flexner Report. A federally led investigation could expose systemic failures and force medical education to modernize.  Listeners can take action today. Dr. Smith provides tools on his website — robertcsmithmd.com — for contacting political leaders and advocating reform.  Buy Has Medicine Lost Its Mind Amazon: https://amzn.to/46Iaw7a Bookshop:https://bookshop.org/a/54587/9781493087655 Connect with Dr. Smith Website https://www.robertcsmithmd.com/ X: https://x.com/RobertCSmithMD Facebook: https://www.facebook.com/RobertCSmithMD LinkedIn: https://www.linkedin.com/in/robertcsmithmd/ Connect with Mike Website: https://uncorkingastory.com/ Youtube: https://www.youtube.com/@uncorkingastory Instagram: https://www.instagram.com/uncorkingastory/ Facebook: https://www.facebook.com/uncorkingastory TikTok: https://www.tiktok.com/@uncorkingastory Twitter: https://twitter.com/uncorkingastory LinkedIn: https://www.linkedin.com/company/uncorking-a-story/ If you like this episode, please share it with a friend. If you have not done so already, please rate and review Uncorking a Story on Apple Podcasts, or wherever you get your podcasts. #MentalHealthCrisis #HealthcareReform #PatientCenteredCare #MedicalEducation #UncorkingAStory #DrRobertSmith #HasMedicineLostItsMind #PrimaryCareMentalHealth Learn more about your ad choices. Visit megaphone.fm/adchoices

Send a Text to the Moms - please include your contact info if you want a response. thanks!Guest:Deb Bushong, MS, LPC-S  -  a  licensed therapist for over 20 years."Conversations Therapy is focused on the therapeutic work that helps develop youth and young adults who are in the early parts of their journey of living with Psychosis. I offer supports of various kinds for the clients but also support and psychoeducation for the parents, family members, and support systems. The goal is to move these young people towards living a recovery-oriented, fulfilling life!"We ask questions (and push back a bit on “psychosis can be a gift”) - and share listener questions as well.Conversations Therapy & Supervision(469) 727-TALK {call or text}https://www.conversationstherapy.orghttps://linktr.ee/deb_bushongNAMI Ask the Expert Webinar: https://www.nami.org/namis-ask-the-expert/nami-ask-the-expert-roles-in-recovery-part-2-parents/Randye's substack:https://randyekaye.substack.com/My daughter thinks we are not her parents, just friends. Is this considered psychosis?Our LO was diagnosed with schizophrenia 2 years ago. He has been so afraid to begin running again for fear the voices will get loud and tell him to stop. Do you have any advice to give him the courage to try the one thing he absolutely loved doing?Advice for a recreation therapist in state hospital. What are the best groups and topics to offer to patients going through the forensic/civil system to prevent readmission/relapse?What to say and not to say to a loved one when they are in psychosis, especially when they cannot recognize that they are having hallucinations.How to help a LO from miles away, while they are in psychosis.-My son laughs a lot and very hearty laughs. But whenever we ask him if he would like to share what the joke is or what's funny. He says no it's nothing.Please ask her if she knows if they ever share that information with anyone ? It's been over 20 years and he still won't reveal anything.What is the difference between psychosis and delusions? And how long can they last? Untreated… this seems to be a major obstacle to getting treatment.This Ability PodcastReal stories, advocacy, and inclusion from the disability community.Listen on: Apple Podcasts SpotifyWant to know more?Join our facebook page Our websites:Randye KayeMindy Greiling Miriam (Mimi) Feldman

10:05 – 10:22 (17mins) Michele SteebCEO of Free Up Foundationwww.FreeUpFoundation.comwww.michelesteeb.comAuthor of Answers Behind the RED DOOR: Battling the Homeless Epidemic MICHELE STEEB: Tragic Tales Demand Reform Across America’s streets, the homeless epidemic is claiming lives, fracturing families, and eroding public safety. Often deeply intertwined with mental illness and addiction, it has become a humanitarian crisis that traps vulnerable individuals in cycles of dependence and despair while destabilizing the communities around them. This crisis has been worsened by policies that elevate the notion of “freedom” over timely, life-saving intervention. Recent events make the consequences of that choice unmistakably clear. Continuing on the current path is neither humane nor responsible. Consider what unfolded in New York City over the holidays. A woman with a documented history of serious mental illness and homelessness was released from psychiatric care, only to purchase a knife hours later, then repeatedly stab a mother changing her baby in a store’s restroom. Thankfully, both mother and child survived. But we must be clear that this was not a random act of violence — it was a foreseeable failure of a system that confuses discharge with success and autonomy with safety. In Honolulu, another homeless individual perished from advanced cancer that physicians later said was treatable with timely intervention. While untreated disease ultimately took his life, it also robbed society of the human potential that could have been restored had policy acknowledged his inability to make informed decisions about his own care. The Reiner family tragedy has laid this failure bare. Two parents, Rob and Michele Reiner, were brutally murdered in their Los Angeles home by their adult son — a heartbreaking outcome in the context of his long struggles with addiction, mental illness, and homelessness. Their surviving children are left traumatized, and their family is irreparably shattered. These are predictable results of public policy choices that ignore anosognosia — a neurological condition common in severe mental illness and addiction that strips individuals of insight into their own impairment. When public policy relies on voluntary compliance alone, this version of “freedom” becomes a slow, preventable death sentence for those least capable of protecting themselves. The result is a system paralyzed by fear of intervention, even as untreated illness escalates into violence, loss, and irreversible harm. For decades, civil commitment standards have been weakened in the name of civil liberties, requiring proof of imminent danger before action can be taken. By the time that threshold is met, irreversible damage has often already occurred. Meanwhile, homelessness is at the highest point ever recorded in our nation’s history, as is the death rate amongst the homeless population, driven largely by addiction as this JAMA study from San Francisco indicates. Voluntary programs help some, but they leave the sickest behind, precisely because many individuals are incapable of making rational decisions about their own care. Housing without treatment does not heal psychosis or addiction. It merely relocates suffering. That is why the Trump Administration’s current push to strengthen civil commitment laws and expand their use represents an overdue and necessary course correction. Expanding the criteria for intervention, requiring treatment plans with accountability, and ensuring continuity of care are acts of moral responsibility. Governments that turn to court-ordered treatment frameworks and supervised care models are beginning to confront a hard truth: When individuals are too ill to recognize their need for help, the humane response is intervention. While the Homeless Industrial Complex insists involuntary treatment undermines civil liberties and that it does not work, it was the abandonment of treatment-first approaches — not their use — that coincided with an increase in homelessness, even as public spending ballooned, all under a promise to end homelessness in a decade. It is a profound injustice to allow people with brain diseases to deteriorate, die, or endanger others in the name of an autonomy they do not meaningfully possess. Addiction and serious mental illness are diseases of the brain, not moral failings. Ignoring them does not preserve freedom; it destroys lives, fractures families, and imposes devastating consequences on communities and society as a whole. Accountable compassion pairs empathy with responsibility. It invests in psychiatric beds, recovery-oriented addiction care, and the resilience of human beings. It recognizes that public safety and human purpose are inseparable values. Untreated mental illness, including improperly treated mental illness, costs the U.S. economy hundreds of billions of dollars annually through emergency care, incarceration, lost productivity, and community destabilization. America cannot afford more preventable deaths on sidewalks, more assaults in public spaces, or more families shattered by untreated disease. Thankfully, this Administration recognizes that a society that refuses to intervene until blood is spilled is not a free society at all. Michele Steeb is the founder of Free Up Foundation and author of “Answers Behind the RED DOOR: Battling the Homeless Epidemic,” based on her 13 years as CEO of Northern California’s largest program for homeless women and children. She is a Visiting Fellow with the Discovery Institute’s Fix Homelessness Initiative. Follow them on Twitter: @SteebMichele and @ DiscoveryCWP.See omnystudio.com/listener for privacy information.

10:05 – 10:22 (17mins) Michele SteebCEO of Free Up Foundationwww.FreeUpFoundation.comwww.michelesteeb.comAuthor of Answers Behind the RED DOOR: Battling the Homeless Epidemic MICHELE STEEB: Tragic Tales Demand Reform Across America’s streets, the homeless epidemic is claiming lives, fracturing families, and eroding public safety. Often deeply intertwined with mental illness and addiction, it has become a humanitarian crisis that traps vulnerable individuals in cycles of dependence and despair while destabilizing the communities around them. This crisis has been worsened by policies that elevate the notion of “freedom” over timely, life-saving intervention. Recent events make the consequences of that choice unmistakably clear. Continuing on the current path is neither humane nor responsible. Consider what unfolded in New York City over the holidays. A woman with a documented history of serious mental illness and homelessness was released from psychiatric care, only to purchase a knife hours later, then repeatedly stab a mother changing her baby in a store’s restroom. Thankfully, both mother and child survived. But we must be clear that this was not a random act of violence — it was a foreseeable failure of a system that confuses discharge with success and autonomy with safety. In Honolulu, another homeless individual perished from advanced cancer that physicians later said was treatable with timely intervention. While untreated disease ultimately took his life, it also robbed society of the human potential that could have been restored had policy acknowledged his inability to make informed decisions about his own care. The Reiner family tragedy has laid this failure bare. Two parents, Rob and Michele Reiner, were brutally murdered in their Los Angeles home by their adult son — a heartbreaking outcome in the context of his long struggles with addiction, mental illness, and homelessness. Their surviving children are left traumatized, and their family is irreparably shattered. These are predictable results of public policy choices that ignore anosognosia — a neurological condition common in severe mental illness and addiction that strips individuals of insight into their own impairment. When public policy relies on voluntary compliance alone, this version of “freedom” becomes a slow, preventable death sentence for those least capable of protecting themselves. The result is a system paralyzed by fear of intervention, even as untreated illness escalates into violence, loss, and irreversible harm. For decades, civil commitment standards have been weakened in the name of civil liberties, requiring proof of imminent danger before action can be taken. By the time that threshold is met, irreversible damage has often already occurred. Meanwhile, homelessness is at the highest point ever recorded in our nation’s history, as is the death rate amongst the homeless population, driven largely by addiction as this JAMA study from San Francisco indicates. Voluntary programs help some, but they leave the sickest behind, precisely because many individuals are incapable of making rational decisions about their own care. Housing without treatment does not heal psychosis or addiction. It merely relocates suffering. That is why the Trump Administration’s current push to strengthen civil commitment laws and expand their use represents an overdue and necessary course correction. Expanding the criteria for intervention, requiring treatment plans with accountability, and ensuring continuity of care are acts of moral responsibility. Governments that turn to court-ordered treatment frameworks and supervised care models are beginning to confront a hard truth: When individuals are too ill to recognize their need for help, the humane response is intervention. While the Homeless Industrial Complex insists involuntary treatment undermines civil liberties and that it does not work, it was the abandonment of treatment-first approaches — not their use — that coincided with an increase in homelessness, even as public spending ballooned, all under a promise to end homelessness in a decade. It is a profound injustice to allow people with brain diseases to deteriorate, die, or endanger others in the name of an autonomy they do not meaningfully possess. Addiction and serious mental illness are diseases of the brain, not moral failings. Ignoring them does not preserve freedom; it destroys lives, fractures families, and imposes devastating consequences on communities and society as a whole. Accountable compassion pairs empathy with responsibility. It invests in psychiatric beds, recovery-oriented addiction care, and the resilience of human beings. It recognizes that public safety and human purpose are inseparable values. Untreated mental illness, including improperly treated mental illness, costs the U.S. economy hundreds of billions of dollars annually through emergency care, incarceration, lost productivity, and community destabilization. America cannot afford more preventable deaths on sidewalks, more assaults in public spaces, or more families shattered by untreated disease. Thankfully, this Administration recognizes that a society that refuses to intervene until blood is spilled is not a free society at all. Michele Steeb is the founder of Free Up Foundation and author of “Answers Behind the RED DOOR: Battling the Homeless Epidemic,” based on her 13 years as CEO of Northern California’s largest program for homeless women and children. She is a Visiting Fellow with the Discovery Institute’s Fix Homelessness Initiative. Follow them on Twitter: @SteebMichele and @ DiscoveryCWP.See omnystudio.com/listener for privacy information.

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. Mark Boulos, Dr. Khullar, and Dr. Mak for an in‑depth discussion on a topic that has challenged clinicians for decades: Are hypnotics safe for patients with untreated obstructive sleep apnea (OSA)? As new therapeutic options emerge and our understanding of comorbid insomnia and sleep apnea (COMISA) evolves, clinicians are increasingly confronted with nuanced decisions about when—and whether—to use hypnotic medications. The guests unpack the latest evidence and share insights from recent studies, including research evaluating dual orexin receptor antagonists (DORAs) such as lemborexant in individuals with sleep apnea. The conversation begins with a review of hypnotic medication classes and explores which agents may be safer in untreated OSA, and which still raise concerns. The panel discusses a recent lemborexant study, its design, population characteristics (including BMI and OSA severity considerations), and whether industry sponsorship played a role. They clarify that while the study did not focus specifically on COMISA, it sheds light on how DORAs perform in people with sleep apnea—particularly in terms of respiratory metrics. Returning from the break, the experts tackle the practical clinical dilemma of treatment sequencing in COMISA: Should clinicians begin with cognitive behavioral therapy for insomnia (CBT‑I), initiate PAP therapy, or consider medications first? They walk through what is known about how different hypnotic classes—including z‑drugs, GABAergic agents, trazodone, and DORAs—affect respiratory drive and sleep architecture. The discussion extends to special circumstances such as REM‑related OSA, where increased REM sleep induced by certain medications may have unique implications. The episode also considers broader emerging questions: Do DORAs improve apnea–hypopnea index (AHI) even without PAP? Can hypnotics be used strategically to improve sleep continuity without worsening respiratory parameters? And will future insomnia care rely on identifying phenotypes that respond differently to GABA‑based medications or wakefulness‑impairment targets? Throughout the conversation, the guests emphasize evidence-based takeaways, including the central finding that DORAs do not appear to worsen OSA‑related metrics, offering reassurance for clinicians navigating complex COMISA treatment plans. Whether you regularly see patients with comorbid insomnia and untreated sleep apnea or simply want clarity on the evolving role of hypnotics in this population, this episode offers practical, research-grounded guidance for clinical decisionmaking. Join us for this important discussion on how hypnotics can be used safely and thoughtfully in patients with untreated OSA.

343: Today I'm joined by Dr. Albert Chung, who is a certified colon and rectal surgeon specializing in hemorrhoids, colorectal cancer, Crohn's Disease, Ulcerative Colitis, Diverticulitis, Anal Fissures and more. In our interview, we hone in on the topic of hemorrhoids and discuss what they are, natural ways to treat them and prevent them, and what we've been doing wrong!  Topics Discussed: → Different types of hemorrhoids → What causes hemorrhoids → What to look for if you have one → When to see a doctor → Typical time it takes for them to go away → Home treatments and what NOT to do → Is surgery for everyone → Different types of surgery options → Surgery recovery time  → What to expect from surgery → How to prevent hemorrhoids  As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Fatty15 | For 15% off the starter kit go to https://fatty15.com/digest → Seven Sundays | Go to https://sevensundays.com/ and use code: lilsip for 20% off Timestamps: → 00:00:00 - Introduction  → 00:02:36 - What are hemorrhoids  → 00:07:10 - Stress & digestion  → 00:09:12 - Sitting too long on the toilet  → 00:10:46 - Office chair donuts  → 00:12:06 - Hemorrhoid treatments  → 00:16:14 - Fiber intake  → 00:20:31 - Hydration level  → 00:23:18 - Size range  → 00:24:35 - When to see a doctor  → 00:26:17 - Recovery time→ 00:29:09 - Hemorrhoid surgery & recovery  → 00:33:43 - Pain management & level → 00:36:35 - Surgery options  → 00:39:03 - Recurrent hemorrhoids  → 00:41:11 - Untreated hemorrhoids  → 00:43:12 - Hemorrhoid prevention  Check Out Dr. Chung: → YouTube: Your Friendly Proctologist | @yourfriendlyproctologist → Instagram: @YourFriendlyProctologist  | https://www.instagram.com/yourfriendlyproctologist/ → Website | https://crsurgeryoc.com  Check Out Bethany: → Bethany's Instagram: @lilsipper → YouTube → Bethany's Website → Discounts & My Favorite Products → My Digestive Support Protein Powder → Gut Reset Book  → Get my Newsletters (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

The government coalition have heavily signaled their 2026 campaign approaches but this has gone mostly missed by the media. NZ infrastructure is on its last legs and there's no overt push to bring that into a national conversation.This episode's co-hostsPhilip, Kyle, SimoneTimestamps0:00 Opening / Introductions2:03 Big Three Missed Reports3:28 Luxon at Waitangi11:39 Winston Peters Testing Facism22:57 David Seymour Colonialism Good, Actually39:09 Wastewater Treatment Plant44:12 Frequency of Disasters58:34 Blocked Fast Track1:09:10 ClosingIntro/Outro by The Prophet MotiveSupport us here: https://www.patreon.com/1of200

Olympic sliding sports – bobsled, luge and skeleton – are known for their speed. Athletes chase medals down a track of ice at up to 80 or 90 mph. With this thrill comes the risk of “sled head.” Athletes use the term to explain the dizziness, nausea, exhaustion and even blackouts that can follow a brain-rattling run. Untreated, this can turn into concussions and subconcussions. But there's still a lot more to learn about this condition. So today, host Emily Kwong speaks with two experts about the medical research into sled head – and how the sport would need to change to protect athletes' brain health.Check out more of NPR's Olympics coverage.Interested in more Olympic science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

A Wellington City Councillor says he's frustrated to see yet another example of the capital's water infrastructure failing. Heavy rain flooded the city's wastewater treatment plant's lower floors, causing sewage to leak into Tarakena Bay, writing off equipment and forcing the plant to shut down. Untreated wastewater is currently flowing into the southern coast, with Wellington Water saying it could take days to fix. Wellington Eastern Ward Councillor Sam O'Brien told Ryan Bridge it's an ongoing issue, and this isn't an isolated thing. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Are you wondering which microphone is the best for your podcast? In today's episode, I'm putting some of the most common options to the test. Listen in for a side-by-side comparison of the more budget-friendly microphone choices available to podcasters. Clocking In with Haylee Gaffin is produced by Gaffin Creative, a podcast production company for creative entrepreneurs. Learn more about our services at Gaffincreative.com, plus you'll also find resources, show notes, and more for the Clocking In Podcast.Find It Quickly: Where I record Clocking In (1:12)Apple Macbook Pro (2:43)Apple Corded Headphones (3:19)Apple Airpods (4:11)Apple Airpod Pro (5:19) Logitech Yeti (5:57)Samson Q2U (7:45)Shure SM58 (8:45)Mentioned in this Episode:The Podcast Gear We're Using On Clocking In: gaffincreative.com/podcast-gear-list-for-clocking-in-with-haylee-gaffinPodcast Gear and Equipment for Beginners: gaffincreative.com/podcast-equipment-for-beginners Apple MacBook Pro: amzn.to/4rUO9EvApple EarPods: amzn.to/3XatnToApple AirPods: amzn.to/4rTzwBtApple AirPods Pro: amzn.to/4rgt1s9Logitech Blue Yeti: amzn.to/3S2XZUPSamson Q2U: amzn.to/3zHCaDWShure SM58: amzn.to/4eP5EzLShure SM7B: amzn.to/3JrDG1RConnect with Haylee:Soundboard Society: gaffincreative.com/soundboardInstagram: instagram.com/hayleegaffinTranscript: https://share.descript.com/view/zD6gdKtl6JN Hosted on Acast. See acast.com/privacy for more information.

ADHD is not just about attention. It is about self-control, self-esteem, and what happens when the brain goes offline. Living with untreated ADHD is not just about missing assignments. It is about moving through the world without a reliable connection between what you know and what you do. In this conversation, I talk with Dr. Karin Varblow, a behavioral pediatrician, former teacher and social worker, neurodivergent adult, and mom to neurodivergent kids. We look closely at what untreated ADHD really costs over a lifetime, from self-esteem and identity to health, safety, relationships, and even life expectancy. Dr. Karin explains why ADHD is not simply a "school problem" and why kids who "know better" still cannot always do better in the moment. She shares her "know and go" model of the brain, which helps make sense of why lectures and bigger consequences do not lead to different behavior, and why kids so often feel confused and ashamed by their own actions. We also talk about sleep, airway, co-occurring conditions, and how things like anxiety, trauma, allergies, and disordered sleep can overlap with ADHD or even mask it. Dr. Karin breaks down what good treatment actually looks like in real life, including medication, parent training, behavior supports, and making daily life more stimulating and relevant for the ADHD brain. If you have ever wondered whether ADHD "really" needs treatment, or felt discouraged by mixed messages, this episode will help you see the bigger picture with more clarity and more compassion for you and your child. Key Takeaways Untreated ADHD is not just about school performance. It affects self-esteem, identity, health, safety, relationships, income, and even life expectancy over time. Research shows that people with untreated ADHD have higher rates of emergency room visits, poverty, incarceration, and an average life expectancy that is years shorter than their non-ADHD peers. Treatment meaningfully improves these outcomes. ADHD is both overdiagnosed and underdiagnosed, and it often shows up alongside other conditions like anxiety, depression, learning differences, sleep disorders, allergies, GI issues, and trauma. Sorting out "what's what" takes time and thoughtful evaluation. Effective ADHD treatment is not one thing. The strongest evidence supports a combination of medication and behavior modification, with behavior modification defined as training and support for parents, not "fixing the child" in a weekly session. Behavior plans that focus only on lectures and bigger consequences usually miss the mark. Most kids already know the rules. The problem is not a lack of knowledge, it is a lack of access to that knowledge in the moment. Dr. Karin's "know and go" model helps explain this: the "know" part of the brain holds rules, values, and experience; the "go" part drives behavior. In ADHD, especially around non-preferred tasks, the "go" can take off before the "know" ever gets a say. That disconnect is why kids so often say "I don't know why I did that" and mean it. They are not being manipulative. They are genuinely confused and often ashamed, because their behavior does not match what they actually believe or want. ADHD brains do have strong executive function in areas of high interest. A child who cannot organize themselves around homework may show incredible focus, planning, and follow-through when building Legos or diving into a favorite topic. Sleep, breathing, immune function, and overall health matter. Airway issues, disordered sleep, allergies, and inflammation can all worsen attention, regulation, and behavior, and sometimes even mimic ADHD. Addressing these pieces is part of good care. Supporting a child with ADHD means changing the story from "try harder" to "let's change how we're asking, what we're asking, and how we're supporting you." When adults focus on relevance, relationship, and realistic support, kids get more access to their best selves. About Karin Varblow Dr. Karin Varblow is a behavioral pediatrician and neurodivergence specialist who has built a career around coordinated, whole-family ADHD care. She earned her BA from Duke University and her MD from The George Washington University School of Medicine as a National Health Service Corps Scholar, and completed her Pediatrics residency at INOVA Fairfax Hospital for Children. Dr. Varblow's work is shaped by her unique path as a former educator and social worker, a former general pediatrician, a parent in a neurodiverse family, and an individual with ADHD herself. She supports families through medication management, parent support, behavior modification, care coordination, advocacy, and strategy development, with a focus on helping children thrive in real life, not just "meet expectations." About Your Host, Gabriele Nicolet I'm Gabriele Nicolet, toddler whisperer, speech therapist, parenting life coach, and host of Complicated Kids. Each week, I share practical, relationship-based strategies for raising kids with big feelings, big needs, and beautifully different brains. My goal is to help families move from surviving to thriving by building connection, confidence, and clarity at home. Complicated Kids Resources and Links:

Board-certified orthopedics and sports medicine provider, Dr. NIKHIL PANDHI, will discuss causes of hip pain and complications if it is left untreated.

Unhealed wounds do not disappear with time. They embed themselves into the heart, the body, and the way we interpret life. In this episode, Dr. Delisa Rodgers unpacks the spiritual, emotional, and biblical reality of unresolved pain and why untreated emotional injuries often surface as destructive patterns, distorted thinking, and internal battles we cannot explain. Drawing from Scripture and Hebrew word studies, this teaching reveals how the heart, the lev, shapes the outflow of our lives, and how God's healing nature, Jehovah Rapha, was revealed not in perfection but in moments of bitterness and pain. You will hear why forgiveness does not require forgetting, how suppressed pain affects the body and mind, and why healing is less about reliving trauma and more about stewarding the soul wisely. This episode bridges biblical truth, trauma awareness, and spiritual authority to offer clarity, compassion, and a pathway toward restoration. If you have ever wondered why certain reactions feel bigger than the moment, why old wounds resurface under pressure, or how God heals what time cannot, this teaching will bring understanding and hope. Healing is possible. Wholeness is biblical. And what is faced in the light no longer has power in the dark.

JCO Editor-in-Chief Dr. Jonathan Friedberg is joined by colleagues Dr. Jennifer Woyach, Dr. Wojciech Jurczak, and Dr. Matthew Davids to discuss simultaneous publications presented at ASH 2025 on pertibrutinib, a new upfront treatment option for patients with chronic lymphocytic leukemia. TRANSCRIPT The disclosures for guests on this podcast can be found in the show notes. Dr. Jonathan Friedberg: I'm Jonathan Friedberg, editor of Journal of Clinical Oncology, and welcome to JCO After Hours, where we are covering two manuscripts that were presented at the American Society of Hematology meeting 2025 in Orlando, Florida. I am delighted to be joined by colleagues on this call to discuss these pivotal manuscripts which cover the topic of pirtobrutinib, a new upfront treatment option for patients with chronic lymphocytic leukemia. I will first just introduce our guests, Dr. Woyach. Dr. Jennifer Woyach: Hi, my name is Jennifer Woyach. I am from the Ohio State University. Dr. Wojciech Jurczak: Hello, I am Wojciech Jurczak, working at the National Research Institute of Oncology in Krakow, Poland. Dr. Matthew Davids: Hi, I am Matthew Davids from Dana-Farber Cancer Institute in Boston. Dr. Jonathan Friedberg: We are going to start by just learning a little bit about these two trials that were both large, randomized phase 3 studies that I think answered some definitive questions. We will start with your study, Jennifer. If you could just describe the design of your study and the patient population. Dr. Jennifer Woyach: Absolutely. So this is the BRUIN CLL-314 study, and this is a phase 3 randomized trial of pirtobrutinib versus ibrutinib in patients with CLL or SLL who had not previously been treated with a covalent BTK inhibitor. The patients were both treatment-naive and relapsed/refractory, about one-third of the patients treatment-naive, the rest relapsed/refractory, and they were stratified based upon 17p deletion and the number of prior lines of therapy. The primary objective was looking at non-inferiority of overall response rate over the entire treated population as well as the relapsed/refractory patient population. Key secondary objectives included progression-free survival in the intention-to-treat and the smaller relapsed/refractory and treatment-naive populations. Dr. Jonathan Friedberg: And just comment a little bit on the risk of the patients. Dr. Jennifer Woyach: This study was fairly typical of this cohort of patients. Within the relapsed/refractory patient population, there was a median of one prior line of therapy in each of the groups, up to nine prior lines of therapy in the patients included on the study. For the overall cohort, about two-thirds of the patients were IGHV unmutated, about 15% had 17p deletion, 30% had TP53 mutations, and about 35% to 40% had a complex karyotype, which is three or more abnormalities. Dr. Jonathan Friedberg: And what were your findings? Dr. Jennifer Woyach: Regarding the primary outcome, which is the focus of the publication, we did find that pirtobrutinib was indeed non-inferior and actually superior to ibrutinib for overall response rate throughout the entire patient population and in both the relapsed/refractory and treatment-naive cohorts. PFS is a little bit immature at this time but is trending towards also being significantly better in pirtobrutinib-treated patients compared with ibrutinib-treated patients. Probably most significantly, we found this to be the case in the treatment-naive cohort where there was a striking trend to an advantage of pirtobrutinib versus ibrutinib. Dr. Jonathan Friedberg: And the follow-up that you have on that progression-free survival? Dr. Jennifer Woyach: So we have about 18 months follow-up on progression-free survival. Dr. Jonathan Friedberg: The second study, Wojciech, can you just go through the design and patient population that you treated? Dr. Wojciech Jurczak: Thank you, Dr. Friedberg, for this question. So the BRUIN CLL-313 study was, in fact, the first phase 3 study with pirtobrutinib in exclusively untreated CLL patients. It was a randomized study where we challenged pirtobrutinib versus bendamustine-rituximab. At the time we designed the protocol, bendamustine-rituximab was an option as a standard of care, and Bruton tyrosine kinase monotherapy was used far more commonly than nowadays. The primary target of the study was progression-free survival. We took all untreated patients except for those with 17p deletions. Therefore, it is a good representation for intermediate risk. We had about 60% of the population, 56 to be precise, which was unmutated, evenly distributed into two treatment arms. 17p deleted cases were excluded, but we had about 7% and 8% of TP53 mutated patients as well as about 11% and 7%, respectively, in the pirtobrutinib and bendamustine-rituximab arm of patients with complex karyotype. The progression-free survival was in favor of pirtobrutinib and was assessed by an independent review committee. What is important is that the progression-free survival of the bendamustine-rituximab arm was actually similar to the other studies addressing the same questions, like the comparison with ibrutinib in the ALLIANCE study or zanubrutinib in the SEQUOIA study. What was different was the hazard ratio. In our study, it was 0.20. It was one of the longest effect sizes noted in the frontline BTK study. It represented an 80% reduction in progression-free survival or death. If we compare it to ibrutinib or zanubrutinib, it was 0.39 and 0.42 respectively. Presumably, this great effect contributed towards a trend of overall survival difference. Although survival data are not mature enough, there is a clear trend represented by three patients we lost in the pirtobrutinib arm versus 10 patients lost in the bendamustine-rituximab arm. This trend in overall survival is becoming statistically significant despite the fact that there was a possibility of crossover, and effectively 52.9 patients, which means 18 out of 34 patients relapsing in the bendamustine-rituximab arm, were treated by pirtobrutinib. Dr. Jonathan Friedberg: I am going to turn it over to Matt. The question is: why study pirtobrutinib in this patient population? And then with these two studies, how do you find the patients that were treated, are they representative of people who you see? And do you see this maybe being approved and more widely available? Dr. Matthew Davids: I think in terms of the first question, why study this in a frontline population, we have seen very impressive data with pirtobrutinib in a very difficult-to-treat population of CLL patients. This was from the original BRUIN phase 1/2 study where most of the patients had at least two or three lines of therapy, often both a covalent BTK inhibitor and the BCL2 inhibitor venetoclax, and yet they were still responding to pirtobrutinib. The drug was also very well tolerated in that early phase experience. And actually, we have seen phase 3 data from the BRUIN 321 study comparing pirtobrutinib to bendamustine and rituximab in a relapse population as well. So I think that really motivated these studies to look at pirtobrutinib as a first therapy. You know, often in other cancers of course, we want to use our best therapy first, and I think these studies are an initial step at looking at that. In terms of the second question around the patient population, these are pretty representative patient populations, I would say, for most frontline CLL studies. We see patients who are a bit younger and fitter than sort of the general population of CLL patients who are treated in clinical practice, and I think that is true here as well. Median age in the sort of mid-60s here is a bit younger than the typical patients we are treating in practice. But that is not different from other CLL frontline studies that we have seen recently, so I think it makes it a little bit easier as we kind of think across studies to feel comfortable that these are relatively similar populations. Dr. Jonathan Friedberg: How do you see this either getting regulatory approval or potentially being used compared to current standard of care options? Dr. Matthew Davids: So my understanding is that both of these trials were designed with registrational intent in the frontline setting, and they are both positive studies. That is certainly very encouraging in terms of the potential for an approval here. We have seen in terms of the FDA recently some concerns around the proportion of patients who are coming from North America, and my understanding is that is relatively low on these two studies. But nonetheless, the datasets are very impressive, and so I think it is certainly supportive of regulatory approval for frontline pirtobrutinib. Dr. Jonathan Friedberg: I will ask Jennifer a question. The control arm in your study was ibrutinib, and I think many in the audience may recognize that newer, second-generation BTK inhibitors like acalabrutinib and zanubrutinib are more frequently used now if monotherapy is decided. How do you respond to that, and how would you put your results in your pirtobrutinib arm in context with what has been observed with those agents? Dr. Jennifer Woyach: Yeah, that is a great question. Even though in the United States we are predominantly using acalabrutinib or zanubrutinib when choosing a monotherapy BTK inhibitor, this is actually not the case throughout the entire world where ibrutinib is still used very frequently. The head-to-head studies of both acalabrutinib and zanubrutinib compared to ibrutinib have shown us pretty well what the safety profile and efficacy profile of the second-generation BTK inhibitors is. So even though we do not have a head-to-head study of acalabrutinib or zanubrutinib versus pirtobrutinib, I think, given the entirety of data that we have with all of the covalent BTK inhibitors, I think we can safely look at the pirtobrutinib arm here, how the ibrutinib arm compares or performs in context with those other clinical trials. And though we really can not say anything about pirtobrutinib versus acalabrutinib or zanubrutinib, I think we can still get a good idea of what might be the clinical scenarios in which you might want to choose pirtobrutinib. Dr. Jonathan Friedberg: And Wojciech, do you agree with that? Obviously, I think you have acknowledged that chemoimmunotherapy is rarely used anymore as part of upfront treatment for CLL. So, I guess a similar question. If you were to put the pirtobrutinib result in your study in context with, I guess, more contemporary type controls, would you agree that it is competitive? Dr. Wojciech Jurczak: Well, I think that that was the last study ever where bendamustine-rituximab was used as a comparator arm. So we should notice that smashing difference. Because if we look at the progression-free survival at two years, we have 93.4% in pirtobrutinib arm versus 70.7% in bendamustine-rituximab arm. Bendamustine-rituximab arm did the same as in the other trials, like ALLIANCE or SEQUOIA. Pirtobrutinib did exceptionally well, as pirto is not just the very best BTK inhibitor overcoming the resistance, but perhaps even more important for the first line, it is very well tolerated and is a very selective drug. Now, if we look at treatment-related adverse events, the discontinuation rate, they were hardly ever seen. If we compared the adverse events in exposure-adjusted incidence, literally all adverse events were two or three times higher in bendamustine-rituximab arm except for the bleeding tendency, which however was predominantly in CTCAE grade 1 and 2 with just 0.7% of grade 3 hemorrhage. Therefore, I think that we should actually put the best and the safest drugs upfront if we may, and pirtobrutinib is, or should be, the first choice if we choose monotherapy. Now, I understand that we are not presenting you the data of pirtobrutinib in combination with anti-CD20 or with BCL2 inhibitors, but that is to come. Dr. Jonathan Friedberg: Matt, how would you envision, were regulatory approval granted and this were an option, using this in the upfront patient population? Is there anybody who you would preferentially use this or start on this treatment? Or would this be something that you would tend to reserve for second line? Dr. Matthew Davids: So I would say that in general for most of my patients who would want to start with a continuous BTK inhibitor, I would still use a covalent BTK inhibitor, and I say that for a couple of reasons despite the very promising data from these studies. The first is that the follow-up for both of these phase 3 trials is still quite short, in the range of a median 18 to 24 months. And we know that CLL is a marathon, not a sprint, and these patients are going to probably be living for a very long time. And we do have much longer follow-up from the covalent BTK inhibitors, median of 10-year follow-up with ibrutinib and five to six years with zanubrutinib and acalabrutinib respectively. And you know, I do not think that the pirtobrutinib is going to fall off a cliff after two years, but on the other hand, I think there is a lot of value to long-term data in this disease, and that is why I think for most of my patients I would stick with covalent BTK inhibitors. But the other important factor that we need to consider is patients who are younger and may have many different CLL treatments over the years. We have to be very careful, I think, about how we sequence these drugs. We know right now that we can start with covalent BTK inhibitors and then subsequently patients will respond well to the non-covalent inhibitor pirtobrutinib in later lines of therapy. But right now we do not have prospective data the other way around. So how will the patients on these studies who progress on pirtobrutinib respond to covalent BTK inhibitors? We do not know yet. There have not been a lot of progression events, which is great, but we would like to see some data in that respect to feel more comfortable with that sequence. Now, I do think that particularly for older patients and those who have significant cardiovascular comorbidities, if they wanted to go on a continuous BTK inhibitor, I do think these data really strongly support using pirtobrutinib as the BTK inhibitor of choice in that population. In particular, the cardiovascular risks with pirtobrutinib seem to be quite low. I was very struck in the comparison with BR that the rate of AFib was equivalent between the two arms of the study. And that is really the first time we have seen that with any of these BTK inhibitors, no elevated risk of AFib in a randomized study. I think that is the population where it will get the most traction first, is the upfront, sort of older patient with significant cardiovascular comorbidities. And as the data from these studies mature, I think that we will start to see more widespread use of pirtobrutinib in the frontline setting. Dr. Jonathan Friedberg: Jennifer, I am just curious if you have any personal experience or heard anecdotally about after progression on pirtobrutinib the use of other BTK inhibitors and whether there is a growing experience there. Dr. Jennifer Woyach: I do not think that there is much clinical experience, you know, as Matt alluded to, it certainly has not been tested yet. There has been some data in relapsed CLL suggesting that in people who have resistance mutations to covalent BTK inhibitors after treatment with pirtobrutinib, sometimes those mutations go away. I think most of us are concerned that they are probably not actually gone but maybe in compartments that we just have not sampled, suggesting that sort of approach where you might sequence a covalent inhibitor after a non-covalent in somebody who had already been resistant probably would not work that well. But, you know, in this setting where people had never been exposed to a covalent BTK inhibitor before, we really have no idea what the resistance patterns are going to be like. We assume they will be the same as what we have seen in relapsed CLL, but I think we just need some longer follow-up to know for sure. Dr. Wojciech Jurczak: If I may confront Dr. Davids about the use of covalent BTK inhibitors upfront, well, I think that we should abandon the idea of using the first and the second and the third generation, at least if we don't have medical lines. If we endlessly block the same pathway, it is not going to be effective. So if pirtobrutinib gets approval in first, second line, we do not necessarily have to use it in the first line. I am not here in a position to defend that we should treat patients with pirtobrutinib upfront and not BCL2 time-limited regimen. However, the way I look at CLL patients when choosing therapy is not just how should I treat them now, but what would be the best regimen in 5, 10 years if I have to re-treat them. And in some instances, the idea may be that in this setting we would like to have a BTK inhibitor upfront to have a BCL2 inhibitor later to make it time-limited. Although I understand and I agree with Matthew that if we have an elderly, fragile population, then the charm of having a drug taken once a day in a tablet with literally few cardiovascular adverse events might be an option. Dr. Jonathan Friedberg: And I will give Matt the last word whether he wants to respond to that, and also just as a forward-looking issue, I know both investigators have implied that there will be future studies looking at combinations with pirtobrutinib, and if you have any sense as to what you would be looking for there. Dr. Matthew Davids: The field really is heading toward time-limited therapy for most patients, I would say. There is a bit of a discrepancy right now in the field between sort of what we are doing in academic practice and what is done sort of more widely in community practice. And so right now we are going to see evolving datasets comparing these approaches. We are already seeing data now from the CLL17 study with ibrutinib comparing continuous to time-limited venetoclax-based therapy, and we are seeing similar efficacy benefits from these time-limited therapies without the need for continuous treatment. And so that is where I think some of the future studies with pirtobrutinib combining it with venetoclax and other partners are so important. Fortunately, several of these studies are already ongoing, including a phase 3 trial called CLL18, which is looking at pirtobrutinib with venetoclax, comparing that to venetoclax and obinutuzumab. So I am optimistic that we are going to be developing these very robust datasets where we can actually use pirtobrutinib in the frontline setting as a time-limited therapy as a component of a multi-drug regimen. So far, those early data are very promising. Dr. Wojciech Jurczak: Perhaps last but not least, in a single center we have treated over 300 patients with pirtobrutinib. So eventually some of them relapsed. And I must say that our experience on BCL2 inhibitors, not just venetoclax but including sonrotoclax, are appealingly good. Therefore, by using pirtobrutinib even earlier, we do not block the efficacy of other compounds. Dr. Jonathan Friedberg: All right. Well, I want to thank all of our speakers. I also want to congratulate our two guests who presented these very influential papers at the ASH Annual Meeting, and chose to publish them in JCO, so we thank you for that, and Dr. Davids for your commentary - really appreciated. That is this episode of JCO After Hours. Thank you for your attention. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Disclosures Dr. Wojciech Jurczak Consulting or Advisory Role: BeiGene, Lilly, Abbvie/Genentech, Takeda, Roche, AstraZeneca Research Funding: Roche, Takeda, Janssen-Cilag, BeiGene, AstraZeneca, Lilly, Abbvie/Genentech Dr. Jennifer Woyach Consulting or Advisory Role: Pharmacyclics, Janssen, AstraZeneca, Beigene, Loxo, Newave Pharmaceutical, Genentech, Abbvie, Merck Research Funding: Company name: Janssen, Schrodinger, beone, Abbvie, Merck, Loxo/Lilly Dr. Matthew Davids Honoraria: Curio Science, Aptitude Health, Bio Ascend, PlatformQ Health, Plexus Consulting or Advisory Role: Genentech, Janssen, Abbvie, AstraZeneca, Adaptive Biotechnologies, Ascentage Pharma, BeiGene, Lilly, Bristol-Myers Squibb, Genmab, Merck, MEI Pharma, Nuvalent, Inc., Galapagos NV, Schroedinger Research Funding: Ascentage Pharma, Novartis, MEI Pharma, AstraZeneca  

According to local health professionals, older adults are increasingly vulnerable to addiction and co-occurring mental health issues — especially in recent years. Substance abuse — most commonly alcohol but also prescription drugs like opioids — doesn't necessarily indicate a mental health condition, but they can often be connected. To get a sense of what lies behind the increase and what treatment options are out there, and what families and caregivers should watch for and how they can support loved ones in seeking help, we talk with someone from the Hazelden Betty Ford Clinic in Naples.

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor dive into the latest U.S. blood pressure guidelines—and reveal why nearly half of all Americans face risks that can no longer be ignored. Early intervention and smart lifestyle changes are at the heart of these new recommendations.Why is high blood pressure such a hidden danger? What do the new “elevated” and “stage one” categories mean for real people? How do doctors decide when it's time for medication versus lifestyle changes? And how does blood pressure connect to kidneys, strokes, and even dementia? Dr. Cooper unpacks the science, gives practical advice, and shares why home monitoring is now a crucial part of medical care.In this conversation-dense episode, the team breaks old myths and empowers listeners to take charge—so that “keeping an eye” on blood pressure becomes active prevention, not passive worry.Key Takeaways:New guidelines lower the bar for concern—120 over 80 is now “caution,” and 130 over 80 is “hypertension.” Early action matters.Untreated high blood pressure can lead to irreversible organ damage, strokes, kidney disease, and cognitive decline.Doctors now have a better toolkit: updated cutoffs, risk “calculators” that include zip code, and clearer protocols for who needs medication right away.Lifestyle changes (fruit, vegetables, less sodium, more movement, quality sleep, stress management, and alcohol moderation) are the first line for many—especially in the “elevated” category.Metabolic syndrome often includes high blood pressure; medicines like GLP-1s and metformin may help regulate pressure as well as metabolism.Accurate home blood pressure monitoring is strongly recommended, with validated cuff meters (not wrist models).Dr. Cooper shares actionable tips:Eat five servings of fruits and vegetables daily for potassium—bananas, spinach, potatoes, kiwis all help.Get a “validated” cuff monitor and check morning/evening, resting, following best practices.Ask your doctor about the new guidelines and risk calculators (found at the American Heart Association website).Notable Quote:“Home readings are very valuable. I really encourage people to look at the Validate BP site, find a good meter, and keep a log. Catching high blood pressure early and treating it aggressively can have profound impacts on your future health.”— Dr. Emily CooperResources from the episode:Fat Science is your source for understanding why blood pressure—and metabolic health—matter more than ever. No diets, no agendas, just science that makes you feel better.This show is informational only, not medical advice.Check out our website to submit a question to the listener mailbag.Have questions for Dr. Cooper, a show idea, feedback, or just want to connect?Email questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.com.Connect with:Dr. Emily Cooper on LinkedInMark Wright on LinkedInAndrea Taylor on Instagram

According to local health professionals, older adults are increasingly vulnerable to addiction and co-occurring mental health issues — especially in recent years. Substance abuse — most commonly alcohol but also prescription drugs like opioids — doesn't necessarily indicate a mental health condition, but they can often be connected. To get a sense of what lies behind the increase and what treatment options are out there, and what families and caregivers should watch for and how they can support loved ones in seeking help, we talk with someone from the Hazelden Betty Ford Clinic in Naples.

Send us a textStart with a person, not a feature list. That's the thread that runs through our conversation with Brandon Sawalich and Dr. Dave Fabry about how hearing technology actually improves lives: by putting the patient first, then letting smart tools do the heavy lifting in the background. We dig into how AI moved from a buzzword to a real advantage in tough listening environments, why sound quality remains the non-negotiable foundation, and how “the ear is the new wrist” reframes what a hearing aid can be.We share the inside story of building Starkey's Omega AI and the eighth generation of sound processing, including DNN 360 and a neuroprocessor designed to make great hearing the default. Think of it as an easy button for clinicians: set a strong baseline fast, then spend time on what only humans can do—listening, coaching, and fitting for comfort. The Da Vinci surgical system offers a useful metaphor: technology doesn't replace expertise; it amplifies it. That's how we see the partnership between AI and hearing care professionals, and why robots won't be fitting ears anytime soon.Beyond better hearing in noise, Brandon and Dave talk about the bigger health picture. Untreated hearing loss intersects with cardiovascular health, cognition, and social engagement. So Starkey built tools that track activity, encourage connection, and enable voice control without adding another gadget to your routine. They're honest about the pushback that comes with change, the “Swiss Army knife” moment, and what they learned about leading with clarity: it's a hearing aid first, with multipurpose superpowers second.If this resonates, follow the show, share it with a friend who's curious about hearing tech, and leave a review so more people can find conversations like this. Your feedback shapes what we build next.Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Facebook: Hearing Matters Podcast

25% of Leftists are on medication. Unbelievable. But if you think that's scary, understand 75% of them are UNTREATED!Information about the crooked Democrats is coming at us fast and furiously. And don't expect it to change.Comey is being arraigned today. We will discuss that more in a bit.Understand that the Jack Smith development doesn't help Comey at all. Kash Patel on Jack Smith evidencePut this information. Subpoenaed 8 Senators. Put it in a lockbox. Put in a vault. Prohibited access. Authorization of AG and FBI Director.Knew where to look. Buried. Wormholed.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Untreated hearing loss can silently drain your health, confidence, and finances. Learn how early screening and today's hearing aids can change your life. To see the video edition of this episode with closed captioning, please go to

Tina Keshani cofounded Seven Starling to fill a care gap for maternal mental health. On Thursday, Keshani and ReThink Impact founder and managing partner Jenny Abramson joined ForbesWomen editor Maggie McGrath to break news about Seven Starling's latest round of funding and what it means for the startup's reach.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Vidcast: https://www.instagram.com/p/DOwbtF0jPOI/Pregnancy is a blessed event, but it is accompanied by discomfort and, at times, outright pain.  The golden rule during these 9 months is to avoid all but absolutely necessary medications. Over the years, the pain and fever medication of choice has been acetaminophen, better known as the brand Tylenol.Now, some government officials are warning that acetaminophen during pregnancy might be linked to the later development of neurodevelopmental disorders including autism and autism spectrum disorders.  Let's review what we do know about this issue.In 2024, epidemiologists, neonatologists, and obstetrician-gynecologists at Sweden's famed Karolinska Institute published a study of nearly 2.5 million Swedish mothers, children and their siblings in the Journal of the American Medical Association or JAMA.  It failed to show any statistically significant increased risk for autism, ADHD-hyperactivity, or intellectual disability associated with acetaminophen use during pregnancy once familial-genetic and shared environmental factors were properly factored. This year, public health researchers from New York's Mount Sinai Medical Center, the University of Southern California, The University of Massachusetts, and Harvard's School of Public Health published their meta-analysis of 26 studies of more than 3.4 million mother-child pairs across North America, Europe, and Asia.They concluded that the evidence was “suggestive but not sufficient to infer causality” between acetaminophen use during pregnancy and later neurodevelopmental disorders.  Potential study shortcomings included:  data regarding maternal drug use relied upon recall; there was data heterogeneity across studies; and there were numerous potential confounding factors.The investigators advise that pregnant women could continue to use acetaminophen if needed, but at the lowest effective dose and for the shortest necessary duration.  They did not recommend complete avoidance of the medication.The bottom line is that acetaminophen, Tylenol, continues to be recommended as the first-line medication for pain and fever during pregnancy in guidelines from the American College of Obstetricians and Gynecologists, Britain's Royal College of Obstetricians and Gynecologists, and other medical organizations.  These organizations warn against the use of ibuprofen, naproxen and other nonsteroidal anti-inflammatory drugs as their use has been associated with birth defects.Clinicians continue to emphasize the need to treat fevers during pregnancy.  Failure to do so increased risks of childhood heart conditions, abdominal wall defects, and improper development of the brain and spinal cord.  Untreated pain and fevers are also associated with miscarriage, preterm birth, and low birth weight.Bottom line: use acetaminophen only when necessary during pregnancy and stop taking it as soon as the need no longer exists.  Everything you put into your body, whether it be medications or food, is a double-edged sword.  This is particularly true during pregnancy.https://www.medscape.com/s/viewarticle/explainer-tylenol-safe-take-during-pregnancy-2025a1000nky?ecd=wnl_tp10_daily_250910_MSCPEDIT_etid7706152&uac=210582CN&impID=7706152https://pubmed.ncbi.nlm.nih.gov/38592388/https://ehjournal.biomedcentral.com/articles/10.1186/s12940-025-01208-0#acetaminophen #tylenol #pregnancy #pain #fever #birthdefects

Untreated hypothyroidism can cause serious health complications such as heart failure and myxedema coma. Author Maria Papaleontiou, MD, of the University of Michigan joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence regarding the epidemiology, diagnosis, clinical presentation, and treatment of primary overt hypothyroidism in nonpregnant adults. Related Content: Hypothyroidism

At least one in five of us have high blood pressure but most of us don't know we have it. Untreated, it can lead to serious problems like stroke, heart attack and kidney failure. Which makes a new discovery by researchers at Waipapa Taumata Rau, University of Auckland all the more exciting. Professor Julian Paton was involved in the research and spoke to Jesse.

Dr. Lynn Hellerstein of Vision Beyond Sight speaks with Dr. Robert Lederman, neuro-developmental optometrist and international speaker, to talk about the big impact of vision to learning and why we are still missing it. “We live in the illusion that seeing is easy.” Robert revealed how myopia or nearsightedness has higher incidents in certain populations, questioned why having myopia as a condition is being considered normal when growing up, and provided myopia prevention tips especially for children. He also delved in the wrong expectations set to optometric vision therapy by pointing out the differences between language-based and vision-based learning difficulties, and how 20-20 vision is not a reliable measure to know if you are meeting the visual demands of your life. Functional testing is inadequate, and seeing a developmental optometrist would solve the undiagnosed and untreated visual inefficiencies that are preventing your child (or even you!) from living a full life. Dr. Lynn Hellerstein, Developmental Optometrist, co-owner of Hellerstein & Brenner Vision Center, P.C., award-winning author and international speaker, holds powerful and inspiring conversations with her guests in the areas of health, wellness, education, sports and psychology. They share their inspirational stories of healing and transformation through their vision expansion. Vision Beyond Sight Podcast will help you see with clarity, gain courage and confidence. Welcome to Vision Beyond Sight! Also available on Apple Podcasts, iTunes, Google Podcasts, Spotify, iHeart Radio, Audible and Stitcher.

A free community laundry service has seen encouraging results in reducing the prevalence of skin infections and scabies in remote Northern Territory communities. Untreated scabies infestations can lead to dangerous secondary infections, which can then be a factor in causing rheumatic heart disease. - Проект бесплатных общественных прачечных показывает обнадеживающие результаты в снижении распространенности кожных инфекций и чесотки в отдаленных поселениях Северной Территории.

Untreated edema can lead to more severe problems such as stasis dermatitis, discomfort/pain, venous ulcerations, progressed lymphedema and decreased mobility. By recognizing and intervening early, we as clinicians can make a significant impact on quality of life for our clients and possibly prevent the progression of this disease. Through improving your assessment skills at the bedside, you can empower your patients to make a significant change in the trajectory of their livelihood. Clinicians that are involved in rehabilitative medicine are a critical piece to guiding their patients to add wellness into their lifespan and demonstrate the impact early intervention can make in our clients' lives. This course will aim to improve the bedside assessment skills of edema, give practical intervention guidance and guide the clinician on specialist referral needs. Through step-by-step descriptions, this education aims to be applicable immediately after learning for edema assessment, interventions and goal setting.   To view accreditation information and access completion requirements to receive a certificate for completing this course, please click here.   The content of this Summit podcast is provided only for educational and training purposes for licensed physical therapists and occupational therapists. This content should not be used as medical advice to treat any medical condition in either yourself or others.

If your child snores loudly more than 3 nights weekly with breathing pauses or hyperactivity, a sleep study may be necessary. Untreated sleep disorders can affect growth and academics, while orthodontic treatments can significantly improve symptoms. Impact Orthodontics offers free airway consultations for Calgary youth. Impact Orthodontics SW City: Calgary Address: 4915 Elbow Drive SW Website: https://impactortho.com/

What's one recipe that changed everything in your kitchen — and maybe even your friendships? If you're a home cook who's ever felt stuck in a rut, outgrown old favorites, or longed for a deeper connection at the dinner table, this episode is for you. We're reflecting on the recipes we return to again and again, and how they shape our kitchens, our routines, and our relationships. Passing a recipe from one friend to another can ripple outward, becoming part of something bigger than just dinner.To celebrate our 200th episode, we're sharing the top 10 recipes that have transformed how we cook and host… and brought us closer as friends. that have transformed how we cook and host… and brought us closer as friends. By the end of this episode, you'll:Discover reliably delicious recipes for entertaining, potlucks, meal delivery, and quick weeknight mealsLearn unexpected tips, from slow cooker short-cuts to the dish that turned a salad-skeptic kid into a salad loverFind out the easiest dessert that we have made dozens of times, and have even served for breakfast!Press play now, and rediscover why cooking at home still feels exciting, nourishing, and new… even after hundreds of meals. ***This week's episode is sponsored by La Baleine, makers of ancestral sea salts harvested from France.A good quality salt can enhance the flavor of just about any dish, and even your next dessert!We love their fine grey sea salt from the mineral-rich clay of the Guérande region. Untreated and additive free, it's hand-harvested using traditional know-how.

A Georgia woman faces a felony murder charge after allegedly neglecting her elderly and disabled mother to the point that the 82-year-old was found adhered to her own bed due to severe bedsores.See omnystudio.com/listener for privacy information.

HIV isn’t over — it’s just been ignored. Black women account for a disproportionate number of new cases, the South is ground zero, and the stigma is still killing us. Roland Martin, Dr. Toyin Nwafor, Raheem DeVaughn, and frontline organizers break the silence on a public health crisis America refuses to face. In response to this staggering trend, Gilead Sciences has launched the Setting the P.A.C.E. initiative. The Prevention, Arts and Advocacy, Community, and Education program is a three-year, $12.6 million commitment aimed at expanding HIV prevention efforts in underserved communities. Dr. Toyin Nwafor, Executive Director of Gilead U.S. HIV Medical Affairs, and Raheem DeVaughn, an award-winning musician and partner in the Gilead Setting the P.A.C.E. initiative.

In this episode, I had the privilege of sitting down with Dr. Titus Chiu, a holistic concussion expert, to explore the intricacies of concussion and post-concussion syndrome. Dr. Chiu shared his personal journey that inspired him to specialize in brain health and develop innovative, natural approaches that go beyond conventional medicine. We discussed what really happens to the brain after a concussion, why every case is unique — like a fingerprint — and why the outdated “one-size-fits-all” approach so often fails. Dr. Chiu highlighted the critical importance of the blood-brain barrier, the autonomic nervous system, and the need to address the physical, chemical, and emotional pillars of brain health for lasting recovery. This conversation reinforced my belief that recovery is always possible with the right diagnosis and a multimodal treatment strategy. If you or someone you know is struggling with lingering brain symptoms, you'll find actionable insights — and real hope — in this episode. Key Takeaways: Concussions can vary greatly and do not always result in loss of consciousness, emphasizing the need for awareness around different symptoms and personalized treatment. A holistic approach involving the physical, chemical, and emotional pillars is crucial in diagnosing and treating post-concussion syndrome effectively. Blood-brain barrier health is essential to prevent ongoing brain inflammation, which can lead to more severe conditions if left untreated. Nutritional interventions, including omega-3 fatty acids and polyphenols, alongside specific supplements, can significantly aid in concussion recovery. The complexity of concussions requires a thoughtful, informed approach using advanced diagnostic tools and interventions for optimal recovery outcomes. More About Dr. Titus Chiu:Dr. Titus Chiu is a two-time #1 bestselling author, award-winning international speaker, and holistic brain expert that specializes in healing concussions, naturally. Dr. Chiu has a passion for empowering health-conscious people with the knowledge, insights, and practical actions needed to heal their brains and reclaim their lives after concussion– through advanced brain testing, state-of-the-art treatment technologies, and his clinically-proven concussion recovery programs. Dr. Chiu is the author of BrainSAVE! and Leaky Brain Fix. He works with patients and private clients from all over the world, both online and in-person at his holistic brain centers in California.   Website PrimexWeightLoss Instagram Facebook Connect with me! Website Instagram Facebook YouTube This podcast episode is sponsored by Professional Co-op®, where clinicians gain exceptional access to industry-leading lab services without the hefty price tag—since 2001, they've been redefining what efficient, patient-focused support looks like. Imagine no hidden fees, no minimums, and only paying for completed tests. Experience lab services that not only meet but also exceed your expectations. Join the co-op trusted by countless licensed clinicians nationwide. Visit www.professionalco-op.com to learn more! For over 50 years, NutriDyn has been a leader in functional nutrition, supporting healthcare practitioners with science-based supplements and unparalleled education. Since 1973, they've pioneered practitioner-exclusive formulas backed by rigorous testing and built on the latest research—delivering quality and peace of mind in every bottle. NutriDyn is more than just a supplement provider. They're committed to empowering practitioners through world-class educational resources, including national conferences, workshops, and seminars led by industry thought leaders. From clinical support to dedicated sales reps, NutriDyn offers an integrated approach to help elevate your practice and patient outcomes. Trusted. Transparent. Practitioner-focused. Join NutriDyn's wellness community and discover functional nutrition tailored for you—create your account today to take the first step toward better health: https://nutridyn.com/mprofile

Interview with Erin Underriner, MD

Vermonters overwhelmingly voted to enshrine reproductive rights in the state constitution in 2022. But what if those rights – to abortion, birth control and other reproductive health services – are nearly impossible to access?Putting care out of reach appears to be the strategy behind the Trump administration's relentless assault on Planned Parenthood, the nation's largest provider of reproductive health care. President Trump's “big beautiful bill” that he signed into law on July 4 includes a provision to defund Planned Parenthood and other organizations that provide abortions. A federal judge has temporarily blocked this provision, but if the Trump administration prevails, Planned Parenthood says that numerous health care centers may close, mostly in states where abortion remains legal.This compounds a problem in Vermont, since half of Planned Parenthood's clinics in the state have closed in the last three years due to an ongoing financial crisis with Planned Parenthood of Northern New England (PPNNE).Medicaid already bans funding for abortions. Most of Planned Parenthood's Medicaid patients who obtain family planning services receive birth control and STI testing. One in four Planned Parenthood patients in Vermont and Maine are insured by Medicaid, and one in five in New Hampshire.“The absurdity of all of this is just so transparent,” Nicole Clegg, CEO of Planned Parenthood of Northern New England, told The Vermont Conversation. “We have long-lasting relationships with our patients. We could be their main provider for years … and to suddenly be told, ‘Sorry, you can't go to that provider anymore because they also provide abortion care' — that's what's happening here. That's the goal.”Clegg emphasized that “the overwhelming majority of what we're providing to patients are disease testing and treatment, cancer screenings, wellness exams, birth control. Those are the primary needs that people have during their reproductive years.”Abortion opponents are “no longer interested in the states where they've been successful in banning abortion. They're now really focused on the states where abortion is still legal, so that includes Vermont, and what they're trying to do is go after providers. So that's the new tactic,” Clegg said.She noted that people seeking an abortion in states where it is banned are increasingly coming to New England for care. She told the story of a couple seeking an abortion who drove from Oklahoma to Vermont “because they felt like that was going to be the safest option for them.”“We live in an area of the country where we are a little bit insulated from this fear, but this fear is very real.”What is motivating the attacks?“It's about abortion. It's about controlling people and their ability to make decisions and decide when to have a family,” Clegg replied.A 2024 Pew survey found that two out of three Americans – and 79% of Vermonters – believe that abortion should be legal in all or most cases.“We needed to sort of wake people up by having them lose these basic rights. That's where we are right now.”One in three women have received care from Planned Parenthood in their lifetime, according to the Kaiser Family Foundation. “There's just no other healthcare provider in our country that has that kind of reach and impact,” Clegg said.I asked Clegg what a world without Planned Parenthood would look like. She cited research on what has happened in areas where a Planned Parenthood health center has closed.“Worse pregnancy outcomes. Increased rates of cancer. Increased rates of unintended pregnancy. Untreated sexually transmitted diseases. Increased rates of HIV and AIDS.”Will Planned Parenthood survive?Clegg noted that this year marks Planned Parenthood's 60th anniversary. “We have touched the lives of more than a million people” in northern New England, she said. “I fundamentally believe we will get through this because people support us. People want to come to us for care. We are embedded in our states and a part of our community in deep ways. We matter too much for our states and our communities to just accept that we would close our doors.”

We have not just one but two guests for you this week - Dr. Steve Truch and Devan Kublik! Steve has over 50 years of experience in education, beginning as a junior high school English teacher and then working as a school psychologist, ultimately founding The Reading Foundation clinics across North America to provide one-on-one therapy for students with learning difficulties. He is the primary author of the Discover educational programs used at the clinics and has written several books and articles on reading and cognitive assessment. His work reflects a continued commitment to aligning educational methods with current research, particularly in the science of reading. Devan Kublik holds a Bachelor of Arts in Linguistics and has been with The Reading Foundation since 1999, currently serving as Director of Standards across all locations. She has held leadership roles in multiple clinics and has contributed to nearly every aspect of the organization, including training, program development, and student assessment. Outside of work, she enjoys traveling, reading, and mountain activities. In our conversation, we discuss the issue of reading proficiency among U.S. students, where only 35% of 4th graders are considered proficient readers. We explore how reading instruction methods have changed and evolved over time, from the whole language method to the current emphasis on the science of reading and phonics. Dr. Truch explains how the speech-to-print method, focusing on teaching the phonemic structure of words and their corresponding visual representations, can be a more effective way to help students learn to read. Devan also highlights the importance of "dosage” (the intensity and duration of intervention) in speeding along the process, especially during the summer when students are not constrained by the school schedule. She shares how the Reading Foundation's programs offer individualized and immersive instruction customized to each student's unique needs, often leading to remarkable changes in their confidence and academic performance. Devan and Dr. Truch stress that while reading instruction has been a longstanding challenge for the education system, solutions that are backed by research are available, and that the key is connecting families with the right resources to help their children overcome reading difficulties and unlock their full potential. So, whether your child is a reluctant reader or has faced persistent challenges, this episode offers valuable insights and a glimmer of hope.   Show Notes: [2:55] - Dr. Truch argues that teaching methods for reading often ignore science and harm struggling learners. [5:20] - Traditional phonics rules are inconsistent, but speech-to-print offers a more logical alternative. [8:49] - Dr. Truch adds that teaching children sound-to-spelling connections can lead to better results than relying on abstract rules. [12:11] - Summer can accelerate reading gains for struggling students via structured but individualized intervention. [15:46] - Proper intervention speeds along progress, especially when it is intensive, customized, and monitored. [18:04] - Summer also allows for customized literacy support based on a student's specific needs. [19:14] - Dr. Truch points out how effective reading intervention depends on both program dosage and using the correct method. [21:37] - Untreated reading struggles often leave lasting emotional damage, sometimes even resembling symptoms of PTSD. [23:29] - When parents lack the training to lead interventions, both they and the children can get frustrated. [25:45] - Rapid emotional changes happen once children experience early success via reading intervention. [27:24] - Early, focused instruction can boost lifelong success for struggling readers, as is backed by data and expert recognition. [30:01] - Hear how, with the right tools, one shy girl gained confidence and began reading aloud at school. [32:17] - Dr. Truch explains how targeted assessments can help pinpoint delays. Links and Related Resources: Episode 27: Why We Need to Support Parents Whose Kids Struggle with Learning with Maria Fagan Hassani Episode 208: Overcoming Dyslexia and Addressing The Reading Crisis with Sally Shaywitz, MD Episode 215: How to Support Students Who Struggle with Reading Comprehension – with Dr. Emily Levy “Reading with Your Child: Teaching Key Concepts and Building Habits of Mind”   Connect with Us: Get on our Email List Book a Consultation Get Support and Connect with a ChildNEXUS Provider Register for Our Self-Paced Mini Courses: Support for Parents Who Have Children with ADHD, Anxiety, or Dyslexia    Connect with the Guests: The Reading Foundation - Website The Reading Foundation LA's Page on ChildNEXUS Email: office@readingfoundation.com 

This week on Fat Science, Dr. Emily Cooper, Andrea Taylor, and Mark Wright uncover the truth about fatty liver disease and its rapid rise in both adults and children. It's estimated 125 million Americans have the disease. Dr. Cooper explains the critical role the liver plays in metabolism—covering hundreds of essential functions—and why fatty infiltration poses serious risks. The episode demystifies diagnosis, risk factors, and treatment options, empowering listeners to take a proactive approach to liver health and metabolic wellness.Key Takeaways:Fatty liver disease, now known as MASLD—Metabolic Dysfunction-Associated Steatotic Liver Disease, affects about 30% of adults, and is rising in youth, especially those with obesity or type-2 diabetes.Risk is not limited to higher body weights; up to 15% of normal-weight people are also affected, with genetics playing a significant role.Diagnosis can be tricky: blood enzymes (ALT, AST) and platelet counts factor into the highly predictive FIB-4 score, while imaging (like fibroscan) provides clarity on severity.Untreated, fatty liver can progress to inflammation, fibrosis, and even require a liver transplant, though early-stage disease is often reversible with proper intervention.Treatment focuses on improving metabolic function—through medication, diabetes management, and sometimes lifestyle changes—as solely relying on diet and exercise may not be enough, particularly for advanced cases.Personal Stories & Practical Advice:Andrea shares her own experience discovering fatty liver disease and seeing rapid improvement after metabolic treatment.The hosts discuss common misconceptions, and why liver health should be checked in both children and adults, regardless of body size or outward health.Resources:Connect with Dr. Emily Cooper on LinkedIn.Connect with Mark Wright on LinkedIn.Connect with Andrea Taylor on Instagram.Fat Science is a podcast on a mission to explain where our fat really comes from and why it won't go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn't a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org or dr.c@fatsciencepodcast.com.Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

Travis Decker's Untreated PTSD - How Military Mental Health Failures Led to Triple Murder Description: The Travis Decker case reveals a devastating failure of military mental health systems that contributed to the brutal murders of three innocent children. Former Army soldier Travis Decker's untreated PTSD and documented mental health struggles were ignored by both military and civilian systems, ultimately leading to the planned killings of his daughters Olivia, Evelyn, and Paityn. Expert psychotherapist Shavaun Scott provides crucial analysis of how military mental health failures enabled this preventable tragedy. Our comprehensive investigation examines how Travis Decker's military service and subsequent mental breakdown created the perfect storm for familicide. Despite his PTSD, homelessness, and dangerous behavior, neither military nor civilian mental health systems provided adequate intervention or treatment. The case exposes critical gaps in how mentally ill veterans are monitored and treated, particularly when they pose risks to family members. Shavaun Scott breaks down the psychological profile of a veteran whose untreated trauma and mental illness escalated to child murder. We analyze how PTSD symptoms can manifest in domestic violence and familicide, the warning signs that were missed, and the specific failures in Decker's treatment history that contributed to this tragedy. The investigation reveals how military culture and inadequate mental health resources failed to address Decker's deteriorating psychological state. This expert analysis explores the intersection of military service, PTSD, and family violence, examining how veterans' mental health crises can escalate to deadly outcomes when proper intervention and treatment are not provided. We discuss the systemic changes needed in military mental health care to prevent similar tragedies and protect veterans' families from the devastating consequences of untreated trauma. The Travis Decker case serves as a stark warning about the deadly consequences when military and civilian systems fail to adequately address veterans' mental health needs and the risks they may pose to their own families. #TravisDecker #PTSD #MilitaryMentalHealth #VeteranCrisis #Familicide #UntreatedTrauma #MentalHealthFailure #TrueCrime #SystemFailure #HiddenKillers Want to comment and watch this podcast as a video?  Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872  

Travis Decker's Untreated PTSD - How Military Mental Health Failures Led to Triple Murder Description: The Travis Decker case reveals a devastating failure of military mental health systems that contributed to the brutal murders of three innocent children. Former Army soldier Travis Decker's untreated PTSD and documented mental health struggles were ignored by both military and civilian systems, ultimately leading to the planned killings of his daughters Olivia, Evelyn, and Paityn. Expert psychotherapist Shavaun Scott provides crucial analysis of how military mental health failures enabled this preventable tragedy. Our comprehensive investigation examines how Travis Decker's military service and subsequent mental breakdown created the perfect storm for familicide. Despite his PTSD, homelessness, and dangerous behavior, neither military nor civilian mental health systems provided adequate intervention or treatment. The case exposes critical gaps in how mentally ill veterans are monitored and treated, particularly when they pose risks to family members. Shavaun Scott breaks down the psychological profile of a veteran whose untreated trauma and mental illness escalated to child murder. We analyze how PTSD symptoms can manifest in domestic violence and familicide, the warning signs that were missed, and the specific failures in Decker's treatment history that contributed to this tragedy. The investigation reveals how military culture and inadequate mental health resources failed to address Decker's deteriorating psychological state. This expert analysis explores the intersection of military service, PTSD, and family violence, examining how veterans' mental health crises can escalate to deadly outcomes when proper intervention and treatment are not provided. We discuss the systemic changes needed in military mental health care to prevent similar tragedies and protect veterans' families from the devastating consequences of untreated trauma. The Travis Decker case serves as a stark warning about the deadly consequences when military and civilian systems fail to adequately address veterans' mental health needs and the risks they may pose to their own families. #TravisDecker #PTSD #MilitaryMentalHealth #VeteranCrisis #Familicide #UntreatedTrauma #MentalHealthFailure #TrueCrime #SystemFailure #HiddenKillers Want to comment and watch this podcast as a video?  Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Every Memory Deserves Respect: EMDR, the Proven Trauma Therapy with the Power to Heal An introduction to EMDR, a proven trauma therapy with the power to heal, cowritten by a world-renowned therapist and a patient who experienced transformative relief through EMDR therapy.Trauma is a part of life.You or someone you care about has probably experienced trauma, whether “big-T” trauma, such as emotional, physical, or sexual abuse or the more common but no less significant “little-t” trauma that can result from divorce, job loss, painful childhood experiences, or any situation where you felt worthless, afraid, or powerless. Untreated trauma can lead to long lasting effects such as depression, anxiety, PTSD, and difficulties maintaining intimate relationships.But the good news is that we can heal—and it doesn't have to take a lifetime. EMDR (which stands for Eye Movement Desensitization and Reprocessing) is a unique type of psychotherapy proven to help people recover from trauma and improve the quality of their lives.Cowritten by a patient who experienced transformative relief from trauma through EMDR therapy, and a world-renowned psychologist who explains exactly how and why EMDR works, Every Memory Deserves Respect provides clear information while offering inspiration and hope.Through compelling science, personal stories, and powerful photographic images, we learn how trauma is stored in the brain and body, continuing to cause pain and suffering, and how EMDR frees us by repatterning our thinking and emotional reactions. It explains why talk therapy has only a limited impact on trauma recovery, describes what to expect from gentle and targeted EMDR therapy, and offers guidance on how to find a therapist who is just right for you. Dr. Deborah Korn, a clinical psychologist with a private practice in Cambridge,MA. She is on the faculties of the EMDR Institute in CA and the Trauma Research Foundation in Boston. She is also an EMDR International, Association-approved Consultant, and presents and consults internationally on the treatment of adult survivors of childhood abuse and neglect. Michael Baldwin is an accomplished leader in the communications industry with more than 35 years of award-winning work in advertising. He is the founder and principal of the branding and communication firm MICHAEL BALDWIN INC, located in New York. Michael is a trauma survivor actively engaged in the process of recovery. You can learn more about each of the authors and about the book by visiting their website everymemorydeservesrespect.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Every Memory Deserves Respect: EMDR, the Proven Trauma Therapy with the Power to Heal An introduction to EMDR, a proven trauma therapy with the power to heal, cowritten by a world-renowned therapist and a patient who experienced transformative relief through EMDR therapy.Trauma is a part of life.You or someone you care about has probably experienced trauma, whether “big-T” trauma, such as emotional, physical, or sexual abuse or the more common but no less significant “little-t” trauma that can result from divorce, job loss, painful childhood experiences, or any situation where you felt worthless, afraid, or powerless. Untreated trauma can lead to long lasting effects such as depression, anxiety, PTSD, and difficulties maintaining intimate relationships.But the good news is that we can heal—and it doesn't have to take a lifetime. EMDR (which stands for Eye Movement Desensitization and Reprocessing) is a unique type of psychotherapy proven to help people recover from trauma and improve the quality of their lives.Cowritten by a patient who experienced transformative relief from trauma through EMDR therapy, and a world-renowned psychologist who explains exactly how and why EMDR works, Every Memory Deserves Respect provides clear information while offering inspiration and hope.Through compelling science, personal stories, and powerful photographic images, we learn how trauma is stored in the brain and body, continuing to cause pain and suffering, and how EMDR frees us by repatterning our thinking and emotional reactions. It explains why talk therapy has only a limited impact on trauma recovery, describes what to expect from gentle and targeted EMDR therapy, and offers guidance on how to find a therapist who is just right for you. Dr. Deborah Korn, a clinical psychologist with a private practice in Cambridge,MA. She is on the faculties of the EMDR Institute in CA and the Trauma Research Foundation in Boston. She is also an EMDR International, Association-approved Consultant, and presents and consults internationally on the treatment of adult survivors of childhood abuse and neglect. Michael Baldwin is an accomplished leader in the communications industry with more than 35 years of award-winning work in advertising. He is the founder and principal of the branding and communication firm MICHAEL BALDWIN INC, located in New York. Michael is a trauma survivor actively engaged in the process of recovery. You can learn more about each of the authors and about the book by visiting their website everymemorydeservesrespect.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychology

Every Memory Deserves Respect: EMDR, the Proven Trauma Therapy with the Power to Heal An introduction to EMDR, a proven trauma therapy with the power to heal, cowritten by a world-renowned therapist and a patient who experienced transformative relief through EMDR therapy.Trauma is a part of life.You or someone you care about has probably experienced trauma, whether “big-T” trauma, such as emotional, physical, or sexual abuse or the more common but no less significant “little-t” trauma that can result from divorce, job loss, painful childhood experiences, or any situation where you felt worthless, afraid, or powerless. Untreated trauma can lead to long lasting effects such as depression, anxiety, PTSD, and difficulties maintaining intimate relationships.But the good news is that we can heal—and it doesn't have to take a lifetime. EMDR (which stands for Eye Movement Desensitization and Reprocessing) is a unique type of psychotherapy proven to help people recover from trauma and improve the quality of their lives.Cowritten by a patient who experienced transformative relief from trauma through EMDR therapy, and a world-renowned psychologist who explains exactly how and why EMDR works, Every Memory Deserves Respect provides clear information while offering inspiration and hope.Through compelling science, personal stories, and powerful photographic images, we learn how trauma is stored in the brain and body, continuing to cause pain and suffering, and how EMDR frees us by repatterning our thinking and emotional reactions. It explains why talk therapy has only a limited impact on trauma recovery, describes what to expect from gentle and targeted EMDR therapy, and offers guidance on how to find a therapist who is just right for you. Dr. Deborah Korn, a clinical psychologist with a private practice in Cambridge,MA. She is on the faculties of the EMDR Institute in CA and the Trauma Research Foundation in Boston. She is also an EMDR International, Association-approved Consultant, and presents and consults internationally on the treatment of adult survivors of childhood abuse and neglect. Michael Baldwin is an accomplished leader in the communications industry with more than 35 years of award-winning work in advertising. He is the founder and principal of the branding and communication firm MICHAEL BALDWIN INC, located in New York. Michael is a trauma survivor actively engaged in the process of recovery. You can learn more about each of the authors and about the book by visiting their website everymemorydeservesrespect.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/spiritual-practice-and-mindfulness

Is it your ex… or your estrogen? In this honest, hilarious, and eye-opening episode, Andrea and Morgan sit down with Joanna Strober, founder and CEO of MIDI, to uncover how midlife hormone shifts can sabotage your divorce (and your sanity). They discuss why so many women feel like they're losing their minds during divorce, how to actually get helpful care without expensive concierge clinics, and what might be missing from your divorce team. Spoiler: it might be estrogen and semaglutide.What you'll learn:What MIDI is—and why it might be your new secret weaponThe signs you're not “just emotional”… your hormones might be offHow perimenopause symptoms overlap with divorce stressWhy good healthcare now can help you make better divorce decisionsWhat hormones like estrogen and testosterone can (and can't) fixThe juicy good truth about weight loss meds like semaglutide (aka Ozempic/Wegovy)How MIDI makes care accessible and insurance-friendlyThe long-term risks of ignoring hormonal healthWhy your second act deserves a thriving body and brainHow to stop using your lawyer as your therapistBurning questions answered in this episode:What the hell is happening to my body during divorce?Can hormones really impact mood, memory, libido, and weight?Is telehealth legit—or should I be worried?What's the real deal with GLP-1s (like semaglutide)?Is testosterone safe for women?How do I know if I'm in perimenopause?What if my insurance doesn't cover this?Could taking care of my hormones have saved my marriage?How do I get started with MIDI?Why is feeling better the key to not sucking at divorce?Check out MIDI: https://www.joinmidi.com/Our Divorce Crash Course was designed to hold your hand through the process and help you avoid major and expensive mistakes. Learn more here: https://www.hownottosuckatdivorce.com/divorce-crash-courseOur Family Wizard is another fantasitc resource for those who need help navigating the "fun" world of coparenting. Head to this landing page to see how we work closely with them to support our listeners! http://www.ourfamilywizard.com/notsuckFriends, slide into our dms, we love love love hearing from you. We are always here to listen and help in any way we can. You've got this and we've got you.Instagram: @hownotosuckatdivorceFollow Andrea: @theandrearappaportFollow Morgan: @divorceattorneychicago

About half of all Americans have gum disease, a chronic condition that can destroy the tissues holding your teeth in place. Untreated, it can lead to the loss of teeth - even healthy ones!While traditional periodontal therapy can be helpful, today, we have new and innovative ways of treating it even more effectively. That's the focus of this latest episode of Your Mouth Matters, in which Dr. T talks with Judy Carroll about her innovative RPE protocol. (“RPE” stands for Regenerative Periodontal Endoscopy.)Judy is a world leader in advanced perioscopy. She's helped thousands of patients with her innovative protocol that starts with a tiny fiber optic camera that's inserted below the gumline so we can see what's happening below the surface. This is combined with micro-ultrasonic piezo technology and the use of regenerative proteins to achieve excellent results in a non-aggressive way.  Listen now to learn all about RPE and the role it can play in helping you on your way back to healthy periodontal tissues to support healthy teeth and a healthy body alike. Learn more about Judy and RPE at PerioPeak Innovations: https://periopeak.com/how-rpe-works/ 

Story at-a-glance Obstructive sleep apnea (OSA) affects nearly a billion people worldwide. It causes breathing interruptions during sleep that prevent you from reaching restorative sleep stages Common symptoms include loud snoring, gasping/choking during sleep, morning headaches, daytime fatigue, difficulty concentrating and mood changes that are often mistaken for normal tiredness Risk factors for OSA include age, excess throat tissue, weak throat muscles, structural airway abnormalities and vitamin D deficiency, which affects sleep regulation and quality Untreated sleep apnea leads to serious health complications including cardiovascular disease, Type 2 diabetes, cognitive decline, weakened immune function and increased accident risk Treatment options include CPAP therapy, oral appliances, orofacial myofunctional therapy and lifestyle changes like optimizing breathing habits, maintaining healthy weight and adjusting sleep position

Send us a textDr. Douglas Beck sits down with Dr. Brandon Paul to unravel the fascinating world of auditory neuroplasticity and its profound implications for hearing health. Dr. Paul shares cutting-edge research on how our brains adapt when hearing diminishes—and what happens when we restore that sensory input.The conversation begins with a clear explanation of neuroplasticity as the brain's ability to reorganize itself throughout our lives, though most actively during early development. When hearing loss occurs, the brain doesn't simply accept reduced input. Instead, neurons become hyperactive through increased spontaneous firing, stronger responses to weak signals, and enhanced neural synchrony—all attempts to maintain their expected level of stimulation.Most remarkable is the phenomenon called cross-modal plasticity. As auditory input decreases, visual processing intensifies in brain regions typically dedicated to hearing. Dr. Paul explains that this isn't a simple takeover but rather an unmasking of existing multisensory connections. Surprisingly, proper hearing aid fitting can reverse this process, normalizing both visual and auditory responses even in older adults.The cognitive implications are significant. Untreated hearing loss forces the brain to rely heavily on internal templates rather than actual sensory input, creating opportunities for miscommunication and increasing cognitive load. This contributes to the well-documented connection between hearing loss and cognitive decline—a risk that multiplies dramatically when combined with untreated vision problems. Whether you're an audiologist, hearing care professional, or someone concerned about hearing health, this episode provides invaluable insights into why early intervention matters. The brain's remarkable adaptability offers hope that appropriate hearing technology can not only improve communication but potentially preserve cognitive function throughout life.While we know all hearing aids amplify sounds to help you hear them, Starkey Genesis AI uses cutting-edge technology designed to help you understand them, too.Click here to find a provider near you and test drive Starkey Genesis AI! Connect with the Hearing Matters Podcast TeamEmail: hearingmatterspodcast@gmail.com Instagram: @hearing_matters_podcast Twitter: @hearing_mattasFacebook: Hearing Matters Podcast

Grief is something we all go through at some point, but most people don't really know how to deal with it.   We're often told that “time heals all wounds” or that “moving on means forgetting,” but those ideas can actually keep us stuck in pain.   In this episode, Tim Ringgold, a board-certified music therapist and grief counselor, joins me to share his powerful story of loss from losing five close friends to the heartbreaking death of his young daughter from a rare disease.   Tim opens up about the importance of music during his dark times and how it can help you heal.   We're talking about why grief doesn't follow a set timeline, how ignoring your emotions keeps you stuck, and how to heal without forgetting the people you've lost.   Tim also explains the best ways to support someone who's grieving. He shares what to say (and what NOT to say) to someone who's hurting.   If you or someone you love has experienced loss, this episode will give you hope, guidance, and practical advice for navigating grief and finding peace again.   This conversation is filled with powerful lessons about love, loss, and learning to live fully again.    So, join us today if you're feeling stuck in sadness, unsure how to move forward, or you just want to know how to be there for someone who's grieving.   Connect with Tim Ringgold: Website: http://CodeRedLifestyle.com/LOSS Instahram: https://www.instagram.com/tim_ringgold/ Linkedin: https://www.linkedin.com/in/timringgold Facebook: https://www.facebook.com/tim.ringgold/     Connect with me!   Facebook: https://www.facebook.com/CodeRedLifestyle/   Instagram: https://www.instagram.com/cristycodered/   Website: https://coderedlifestyle.com/⁠

In episode 282 of The Super Human Life, Coach Frank Rich sits down with Dr. Samantha Harte to dive deep into the flaws of traditional recovery programs and why breaking free from shame and embracing self-forgiveness is critical for true healing. Samantha shares her powerful journey through addiction, loss, and transformation—showing us how self-compassion, intuition, and a holistic approach to fitness and nutrition can lead to lasting change. We explore why so many recovery programs fall short, the role of grief in personal growth, and how facing our own mortality can push us toward becoming the best version of ourselves. She also breaks down the inspiration behind her book, Breaking the Circuit, a modern take on the 12 steps, designed to help anyone—addict or not—rewire their mind for resilience, purpose, and joy. If you're looking for a new way to approach recovery, personal growth, and transformation, this conversation is a must-listen. Key Takeaways: